保妇康栓联合头孢地尼及奥硝唑治疗慢性盆腔炎的疗效评价
|
摘要
目的:研究保妇康栓联合头孢地尼及奥硝唑治疗慢性盆腔炎的临床价值。方法:选取我院120例慢性盆腔炎患者,随机分为对照组和实验组,对照组予头孢地尼联合奥硝唑治疗,实验组予中药保妇康栓阴道内给药联合头孢地尼及奥硝唑口服治疗,比较两组治疗效果、复发率及不良反应。结果:实验组治疗总有效率显著高于对照组,差异有统计学意义(P<0.05);两组治疗的不良反应无明显差异(P>0.05)。结论:保妇康栓、头孢地尼和奥硝唑治疗慢性盆腔炎疗效显著,值得推广。
Objective:To study the clinical value of Baofu Kang suppository combined with cefdinir and ornidazole in the treatment of chronic pelvic inflammation. Methods:120 patients with chronic pelvic inflammation were randomly divided into control group and experimental group,And the control group were treated with cefdinir combined with ornidazole,while the experimental group were treated with Baofu Kang suppository combined with oral administration of cefdinir and ornidazole. Results:The total effective rate of chronic pelvic inflammation in the experimental group was significantly higher than that in the control group(P<0.05),however,there were no significant differences in adverse reactions between the two groups(P >0.05). Conclusion:Baofu Kang suppository combined with cefidipine and ornidazole in the treatment of chronic pelvic inflammatory disease are effective and worthy of promotion.
Objective:To study the clinical value of Baofu Kang suppository combined with cefdinir and ornidazole in the treatment of chronic pelvic inflammation. Methods:120 patients with chronic pelvic inflammation were randomly divided into control group and experimental group,And the control group were treated with cefdinir combined with ornidazole,while the experimental group were treated with Baofu Kang suppository combined with oral administration of cefdinir and ornidazole. Results:The total effective rate of chronic pelvic inflammation in the experimental group was significantly higher than that in the control group(P<0.05),however,there were no significant differences in adverse reactions between the two groups(P >0.05). Conclusion:Baofu Kang suppository combined with cefidipine and ornidazole in the treatment of chronic pelvic inflammatory disease are effective and worthy of promotion.
引文
[1]巩路.常用抗菌药物作用特点及合理选择[J].中国实用妇科与产科杂志,2012(7):541-543.
[2]中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(修订版)[J].中华妇产科杂志,2014,49(6):42-43.
[3]周争立,袁涛.急慢性盆腔炎性疾病的病原体检测研究[J].中国妇幼保健,2014,29(11):1684-1687.
[4]王滨.保妇康栓联合头孢曲松钠、甲硝唑治疗慢性盆腔炎的临床效果观察[J].家庭医药·就医选药,2017(9).
[5]房海飞.头孢地尼联合奥硝唑治疗盆腔炎临床效果观察[J].中外女性健康研究,2016(1):164.
[6]卢大群,闫晓丹.头孢地尼胶囊合奥硝唑治疗慢性盆腔炎70例临床观察[J].中国民族民间医药,2014(15):61.
[7]Smith KJ,Ness RB,Wiesenfeld HC,et al.Cost-effectiv-eness of alternative outpatient pelvic inflammatory dis-ease treatment strategies[J].Sex Transm Dis,2007,34(12):960-966.
[8]阮越容,范氏凤,董莉.中医治疗慢性盆腔炎临床研究进展[J].山东中医药大学学报,2016(3):293-296.
[9]冯彦君,谢京蕊,陈继兰,等.慢性盆腔炎的中医药研究进展[J].光明中医,2016,31(14):2142.
[10]狄文,徐亚楠.盆腔炎性疾病的抗生素治疗[J].中国实用妇科与产科杂志,2012,28(7):496-498.
[2]中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(修订版)[J].中华妇产科杂志,2014,49(6):42-43.
[3]周争立,袁涛.急慢性盆腔炎性疾病的病原体检测研究[J].中国妇幼保健,2014,29(11):1684-1687.
[4]王滨.保妇康栓联合头孢曲松钠、甲硝唑治疗慢性盆腔炎的临床效果观察[J].家庭医药·就医选药,2017(9).
[5]房海飞.头孢地尼联合奥硝唑治疗盆腔炎临床效果观察[J].中外女性健康研究,2016(1):164.
[6]卢大群,闫晓丹.头孢地尼胶囊合奥硝唑治疗慢性盆腔炎70例临床观察[J].中国民族民间医药,2014(15):61.
[7]Smith KJ,Ness RB,Wiesenfeld HC,et al.Cost-effectiv-eness of alternative outpatient pelvic inflammatory dis-ease treatment strategies[J].Sex Transm Dis,2007,34(12):960-966.
[8]阮越容,范氏凤,董莉.中医治疗慢性盆腔炎临床研究进展[J].山东中医药大学学报,2016(3):293-296.
[9]冯彦君,谢京蕊,陈继兰,等.慢性盆腔炎的中医药研究进展[J].光明中医,2016,31(14):2142.
[10]狄文,徐亚楠.盆腔炎性疾病的抗生素治疗[J].中国实用妇科与产科杂志,2012,28(7):496-498.